Acura Pharmaceuticals Inc (ACUR)
0.01
0.00 (0.00%)
USD |
OTCM |
Apr 22, 16:00
Acura Pharmaceuticals Cash from Financing (TTM): -0.008M for Sept. 30, 2021
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2021 | 0.394M |
September 30, 2021 | -0.008M |
June 30, 2021 | 0.261M |
March 31, 2021 | 0.53M |
December 31, 2020 | 0.27M |
September 30, 2020 | -0.005M |
June 30, 2020 | -0.005M |
March 31, 2020 | 0.987M |
December 31, 2019 | 1.389M |
September 30, 2019 | 2.96M |
June 30, 2019 | 3.161M |
March 31, 2019 | 2.663M |
December 31, 2018 | 1.779M |
September 30, 2018 | -0.462M |
June 30, 2018 | 2.644M |
March 31, 2018 | 1.204M |
December 31, 2017 | 1.24M |
September 30, 2017 | 1.317M |
June 30, 2017 | -2.627M |
March 31, 2017 | -2.575M |
December 31, 2016 | -2.539M |
September 30, 2016 | -2.471M |
June 30, 2016 | 4.612M |
March 31, 2016 | 4.881M |
December 31, 2015 | 5.291M |
Date | Value |
---|---|
September 30, 2015 | 6.091M |
June 30, 2015 | -0.355M |
March 31, 2015 | 0.001M |
December 31, 2014 | -0.52M |
September 30, 2014 | 9.249M |
June 30, 2014 | 12.23M |
March 31, 2014 | 12.48M |
December 31, 2013 | 12.29M |
September 30, 2013 | 2.518M |
June 30, 2013 | -0.464M |
March 31, 2013 | -0.72M |
December 31, 2012 | -1.038M |
September 30, 2012 | -1.045M |
June 30, 2012 | -1.046M |
March 31, 2012 | -0.764M |
December 31, 2011 | -0.541M |
September 30, 2011 | -0.532M |
June 30, 2011 | -0.532M |
March 31, 2011 | -0.417M |
December 31, 2010 | 0.392M |
September 30, 2010 | 0.552M |
June 30, 2010 | 0.552M |
March 31, 2010 | 0.16M |
December 31, 2009 | |
September 30, 2009 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.008M
Minimum
Sep 2021
3.161M
Maximum
Jun 2019
0.9031M
Average
0.394M
Median
Dec 2021
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |
Oragenics Inc | 0.2839M |